Robert S. Mills - 29 Dec 2022 Form 4 Insider Report for TFF Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Robert S. Mills by Kirk Allen Coleman, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
29 Dec 2022
Net transactions value
$0
Form type
4
Filing time
30 Dec 2022, 15:53:22 UTC
Next filing
15 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TFFP Stock Options (Right to Buy) Award $0 +33,475 $0.000000 33,475 29 Dec 2022 Common Stock 33,475 $0.8500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options represent the annual option grant to non-executive members of the Board of Directors.